NRC Health Goodwill, Acquired During Period
NRC Health (NRC) reported Goodwill, Acquired During Period of $4.34 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-03.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2023-03-03
- NRC Health goodwill, acquired during period for the quarter ending 2021-12-31 was $0.00.
- NRC Health goodwill, acquired during period for the quarter ending 2021-09-30 was $0.00.
- NRC Health goodwill, acquired during period for the quarter ending 2021-06-30 was $0.00.
- NRC Health goodwill, acquired during period for the quarter ending 2021-03-31 was $4.34M.
- NRC Health goodwill, acquired during period for fiscal 2021 was $4.34M.
- NRC Health goodwill, acquired during period for fiscal 2014 was $1.12M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $0.00 derived: sum of 2 quarters · filed 2023-03-03 | $0.00 derived: sum of 3 quarters · filed 2023-03-03 | $4.34M 10-K · filed 2023-03-03 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $4.34M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $4.34M 10-Q · filed 2021-08-06 | ||
| 2021-03-31 | $4.34M 10-Q · filed 2021-05-07 | |||
| 2014-12-31 | $1.12M 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |